Harbor Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.3K | Sell |
171
-218
| -56% | -$88.4K | 0.01% | 564 |
|
|
2025
Q1 | $194K | Buy |
389
+91
| +31% | +$45.3K | 0.02% | 373 |
|
|
2024
Q4 | $155K | Buy |
298
+3
| +1% | +$1.56K | 0.01% | 381 |
|
|
2024
Q3 | $182K | Sell |
295
-36
| -11% | -$22.3K | 0.02% | 355 |
|
|
2024
Q2 | $183K | Buy |
331
+4
| +1% | +$2.21K | 0.02% | 350 |
|
|
2024
Q1 | $190K | Buy |
327
+1
| +0.3% | +$581 | 0.02% | 348 |
|
|
2023
Q4 | $173K | Sell |
326
-1,036
| -76% | -$549K | 0.02% | 345 |
|
|
2023
Q3 | $689K | Sell |
1,362
-276
| -17% | -$140K | 0.09% | 167 |
|
|
2023
Q2 | $855K | Sell |
1,638
-75
| -4% | -$39.1K | 0.12% | 155 |
|
|
2023
Q1 | $987K | Sell |
1,713
-28
| -2% | -$16.1K | 0.15% | 135 |
|
|
2022
Q4 | $959K | Sell |
1,741
-254
| -13% | -$140K | 0.15% | 137 |
|
|
2022
Q3 | $1.01M | Buy |
1,995
+176
| +10% | +$89.3K | 0.17% | 115 |
|
|
2022
Q2 | $988K | Buy |
1,819
+59
| +3% | +$32K | 0.16% | 119 |
|
|
2022
Q1 | $1.04M | Buy |
1,760
+195
| +12% | +$115K | 0.14% | 131 |
|
|
2021
Q4 | $1.04M | Sell |
1,565
-33
| -2% | -$22K | 0.13% | 135 |
|
|
2021
Q3 | $913K | Buy |
1,598
+77
| +5% | +$44K | 0.12% | 142 |
|
|
2021
Q2 | $767K | Buy |
1,521
+14
| +0.9% | +$7.06K | 0.1% | 165 |
|
|
2021
Q1 | $688K | Buy |
1,507
+437
| +41% | +$200K | 0.1% | 165 |
|
|
2020
Q4 | $498K | Buy |
1,070
+271
| +34% | +$126K | 0.08% | 185 |
|
|
2020
Q3 | $353K | Buy |
799
+241
| +43% | +$106K | 0.07% | 198 |
|
|
2020
Q2 | $202K | Buy |
558
+51
| +10% | +$18.5K | 0.04% | 259 |
|
|
2020
Q1 | $144K | Buy |
507
+182
| +56% | +$51.7K | 0.04% | 269 |
|
|
2019
Q4 | $106K | Buy |
+325
| New | +$106K | 0.02% | 316 |
|